Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
Clinical trial NCT06303167 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06303167
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-08
- Primary completion
- 2023-02-26
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.